Aldeyra Therapeutics (ALDX) Posts Q1 Loss of $1.56/Share

Aldeyra Therapeutics (NASDAQ: ALDX) reported Q2 EPS of ($1.56), $1.03 worse than the analyst estimate of ($0.53).

For earnings history and earnings-related data on Aldeyra Therapeutics (ALDX) click here.

You May Also Be Interested In

• North American Construction (NOA) Tops Q2 EPS by 9c; Offers Guidance
• SeaStar Medical (ICU) Misses Q1 EPS by 4c
• ArriVent BioPharma, Inc. (AVBP) Misses Q2 EPS by 13c